PP
IBB icon

PrairieView Partners’s iShares Biotechnology ETF IBB Stock Holding History

PrairieView Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-147
Closed -$17K – 391
2023
Q3 		$17K Hold
147
– – ﹤0.01% 252
2023
Q2 		$18K Buy
+147
New +$19.1K ﹤0.01% 277

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PrairieView Partners's IBB Position: Q4 2023 in Review

PrairieView Partners sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 147 shares — an estimated $17K sold.

PrairieView Partners first reported a position in IBB in Q2 2023 and held it in 2 quarters. The position peaked at $18K in Q2 2023. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • PrairieView Partners reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • PrairieView Partners sold 147 iShares Biotechnology ETF shares in Q4 2023, an estimated $17K.
  • PrairieView Partners first reported a position in iShares Biotechnology ETF in Q2 2023 and held it in 2 quarters.
  • PrairieView Partners's iShares Biotechnology ETF position peaked at $18K in Q2 2023.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on PrairieView Partners's 13F filing for Q4 2023, filed 26 Jan 2024.